Save time and get answers to complex questions with AI chat
Excipients list used in dexamethasone creams?Bortezomib market france?Zemdri nce gain exclusivity 2028 patent 2031?Can wine consumption affect lipitor's cholesterol lowering ability?Albendazole side effects in humans?
See the DrugPatentWatch profile for crestor
Crestor (rosuvastatin) and Lipitor (atorvastatin) are both statins that lower LDL cholesterol by inhibiting HMG-CoA reductase. Crestor is generally stronger on a milligram-per-milligram basis, achieving greater LDL reductions at equivalent or lower doses.[1][2]
Doctors choose Crestor for patients with very high LDL (>190 mg/dL), familial hypercholesterolemia, or when Lipitor fails to hit targets. Crestor also raises HDL slightly more and lowers triglycerides better at high doses.[2][4] Lipitor is often first-line due to its longer track record and generic availability since 2011.
Both cause muscle pain (myalgia) in 5-10% of users, with rare rhabdomyolysis. Crestor has higher rates of diabetes risk (0.2-0.5% increased incidence) and proteinuria at high doses. Lipitor may cause more liver enzyme elevations. No clear winner on safety—depends on patient factors like kidney function.[3][5]
Generics for both are widely available: - Generic rosuvastatin (Crestor): $10-30/month. - Generic atorvastatin (Lipitor): $5-20/month. Lipitor is cheaper due to earlier patent expiry (May 2011 vs. Crestor's August 2016).[6]
AstraZeneca makes Crestor; Pfizer makes Lipitor. Both are off-patent with multiple generics. No active exclusivity blocks competition.[6] [1] Jones et al., Am J Cardiol (2003) [2] NEJM STELLAR trial (2005) [3] FDA labels comparison [4] AHA statin guidelines (2009) [5] JUPITER trial safety data (2010) [6] DrugPatentWatch.com - Crestor patents DrugPatentWatch.com - Lipitor patents
Other Questions About Crestor :